BRISTOLMYERSDRNBRISTOLMYERSDRNBRISTOLMYERSDRN

BRISTOLMYERSDRN

No trades
See on Supercharts
Market capitalization
‪534.46 B‬BRL
0.01BRL
‪−48.24 B‬BRL
‪260.38 B‬BRL
Beta (1Y)
−0.59

About Bristol-Myers Squibb Company


CEO
Christopher S. Boerner
Website
Headquarters
Princeton
Founded
1933
ISIN
BRBMYBBDR000
FIGI
BBG0025NPDT2
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Check out other big names from the same industry as BMYB34.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
C
BMY3685700
Celgene Corporation 5.7% 15-OCT-2040
Yield to maturity
Maturity date
Oct 15, 2040
BMY5007342
Bristol-Myers Squibb Company 3.4% 26-JUL-2029
Yield to maturity
Maturity date
Jul 26, 2029
BMY.GC
Bristol-Myers Squibb Company 6.875% 01-AUG-2097
Yield to maturity
Maturity date
Aug 1, 2097
C
BMY4560450
Celgene Corporation 3.45% 15-NOV-2027
Yield to maturity
Maturity date
Nov 15, 2027
BMY5077468
Bristol-Myers Squibb Company 1.45% 13-NOV-2030
Yield to maturity
Maturity date
Nov 13, 2030
BMY.GN
Bristol-Myers Squibb Company 6.125% 01-MAY-2038
Yield to maturity
Maturity date
May 1, 2038
C
BMY4560589
Celgene Corporation 4.35% 15-NOV-2047
Yield to maturity
Maturity date
Nov 15, 2047
BMY4831822
Bristol-Myers Squibb Company 3.2% 15-JUN-2026
Yield to maturity
Maturity date
Jun 15, 2026
C
BMY4597874
Celgene Corporation 4.55% 20-FEB-2048
Yield to maturity
Maturity date
Feb 20, 2048
C
BMY4036425
Celgene Corporation 5.25% 15-AUG-2043
Yield to maturity
Maturity date
Aug 15, 2043
BMY4831828
Bristol-Myers Squibb Company 4.25% 26-OCT-2049
Yield to maturity
Maturity date
Oct 26, 2049

See all BMYB34 bonds